Amgen Inc. (AMGN)
NASDAQ·Healthcare·Drug Manufacturers - General
$338.53
-0.49%
Mkt Cap $188.76B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 3, 2026 | $9.47B | $9.87B | +4.14% | $4.73 | $5.29 | +11.84% | — | — |
| Q4 2025 Nov 4, 2025 | $8.97B | $9.56B | +6.59% | $5.02 | $5.64 | +12.35% | — | — |
| Q3 2025 Aug 5, 2025 | $8.94B | $9.17B | +2.59% | $5.28 | $6.02 | +14.02% | — | — |
| Q2 2025 May 1, 2025 | $8.06B | $8.15B | +1.14% | $4.27 | $4.90 | +14.75% | — | — |
| Q1 2025 Feb 4, 2025 | $8.88B | $9.09B | +2.31% | $5.04 | $5.31 | +5.36% | — | — |
| Q4 2024 Oct 30, 2024 | $8.50B | $8.50B | +0.06% | $5.11 | $5.58 | +9.20% | — | — |
| Q3 2024 Aug 6, 2024 | $8.35B | $8.39B | +0.43% | $4.98 | $4.97 | -0.20% | — | — |
| Q2 2024 May 2, 2024 | $7.45B | $7.45B | -0.06% | $3.88 | $3.96 | +2.06% | — | — |
| Q1 2024 Feb 6, 2024 | $8.13B | $8.20B | +0.86% | $4.59 | $4.71 | +2.61% | — | — |
| Q4 2023 Oct 31, 2023 | $6.62B | $6.90B | +4.33% | $4.65 | $4.96 | +6.67% | — | — |
| Q3 2023 Aug 3, 2023 | $6.68B | $6.99B | +4.64% | $4.44 | $5.00 | +12.61% | — | — |
| Q2 2023 Apr 27, 2023 | $6.65B | $6.11B | -8.17% | $3.85 | $3.98 | +3.38% | — | — |
| Q1 2023 Jan 31, 2023 | $6.74B | $6.84B | +1.41% | $4.04 | $4.09 | +1.24% | — | — |
| Q4 2022 Nov 3, 2022 | $6.56B | $6.65B | +1.34% | $4.44 | $4.70 | +5.86% | — | — |
| Q3 2022 Aug 4, 2022 | $6.53B | $6.59B | +0.96% | $4.40 | $4.65 | +5.68% | — | — |
| Q2 2022 Apr 27, 2022 | $6.07B | $6.24B | +2.78% | $4.22 | $4.25 | +0.71% | — | — |
| Q1 2022 Feb 7, 2022 | $6.87B | $6.85B | -0.34% | $4.08 | $4.36 | +6.86% | — | — |
| Q4 2021 Nov 2, 2021 | $6.71B | $6.71B | -0.08% | $4.22 | $4.67 | +10.66% | — | — |
| Q3 2021 Aug 3, 2021 | $6.45B | $6.53B | +1.18% | $4.13 | $4.38 | +6.05% | — | — |
| Q2 2021 Apr 27, 2021 | $6.29B | $5.90B | -6.12% | $4.05 | $3.70 | -8.64% | — | — |